Ilvars Silins - Gynecology

Author Information

Ilvars Silins is a distinguished researcher affiliated with the Department of Obstetrics and Gynecology at Uppsala University Hospital, as well as the Department of Surgical Sciences at Uppsala University in Uppsala, Sweden. His work primarily focuses on gynecological oncology, with significant contributions to understanding ovarian cancer and its surgical outcomes.

Research Contributions

Ilvars Silins has made substantial contributions to the field of gynecology, particularly in the study and treatment of ovarian cancer. His research has explored various aspects of ovarian cancer, including the predictive value of the Peritoneal Cancer Index (PCI) for surgical outcomes and complications, the feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC), and the validation of imaging techniques like PET/MRI for assessing peritoneal carcinomatosis. Silins has also delved into the genetic and molecular aspects of ovarian and cervical cancers, contributing to a more comprehensive understanding of these diseases.

Aliases

Ilvars Silins is also known by several aliases, including I Silins and Ilvar Silins.

Publication and Citation Metrics

Metric	Value
H-index	17
Paper Count	27
Citation Count	1474

Publications:

Peritoneal cancer index predicts severe complications after ovarian cancer surgery.

DOI: 10.1016/j.ejso.2021.05.019

Year: 2021

Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study

DOI: 10.1186/s40644-021-00399-2

Year: 2021

The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer

DOI: 10.1245/s10434-020-08649-6

Year: 2020

EP879 Peritoneal cancer index (PCI) is a strong predictor of operability in ovarian cancer

DOI: 10.1136/ijgc-2019-esgo.927

Year: 2019

EP907 Hyperthermic intraperithoneal chemotherapy (HIPEC) for ovarian cancer treatment: the feasibility study

DOI: 10.1136/ijgc-2019-esgo.953

Year: 2019

Comparison Of Pet-Mri And Mri Alone Predicting Carcinomatosis In Ovarian Cancer Using Peritoneal Cancer Index (Pci)

DOI: 10.1097/01.IGC.0000527296.86225.87

Year: 2017

Complications Related To Surgery For Ovarian Cancer With Intestinal Involvement

DOI:

Year: 2015

Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies

DOI: 10.1158/1055-9965.EPI-08-1186

Year: 2009

Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map

DOI: 10.1002/gcc.20628

Year: 2009

Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma

DOI: 10.1002/cncr.23140

Year: 2008

How Does Hyperthyroidism Affect Gynecological Health?

What Are the Challenges Related to PTO in Gynecology?

What are Prophylactic Measures in Gynecology?

How do lifestyle factors influence gynecological health risks?

How does physical inactivity affect menopausal symptoms?

What are the Symptoms of Preeclampsia?

How Can Technology Aid in Promoting Hand Hygiene?

Which Echinocandins are commonly used?

How to Implement Quality Assurance?

What Role do Hormones Play in These Cancers?

Partnered Content Networks

Relevant Topics